Back to News

From Mahakumbh to Metaverse, Taking AI beyond Internet Connectivity: Inside Ankush Sabharwal’s (Founder & CEO, CoRover) AI Revolution

Analytics Insight
Jul 21, 2025 11:54
Market Trends
1 views
aianalyticsbig-databusiness

Summary

Ankush Sabharwal, Founder & CEO of CoRover, is pioneering AI solutions that function beyond traditional internet connectivity, enabling access in remote and underserved regions, such as during the Mahakumbh festival. This innovation expands the reach of AI-powered services and virtual experiences, highlighting the potential for inclusive digital transformation and bridging the digital divide.

Read Full ArticleMore News

Related Articles

XRP vs Chainlink: Which Crypto Could Make You a Millionaire?

Analytics InsightJul 22

The article compares XRP and Chainlink, analyzing their potential to generate significant returns for investors. While primarily focused on cryptocurrency investment, it highlights how Chainlink’s AI-driven smart contract capabilities could play a pivotal role in the future of decentralized finance. This suggests that advancements in AI integration with blockchain technology may influence the success and adoption of such digital assets.

Skipped Early Cardano (ADA)? Don’t Miss Ruvi AI’s (RUVI) Audited Token While Still Cheap, Experts Say It’s Next to Rally

Analytics InsightJul 22

The article highlights Ruvi AI's (RUVI) audited token as a promising investment opportunity in the AI sector, drawing comparisons to the early days of Cardano (ADA). Experts suggest that RUVI's low current price and recent audit position it for significant growth, signaling increasing investor interest in AI-driven blockchain projects. This trend underscores the growing convergence of AI and blockchain technologies in the crypto market.

AI-Designed Drugs Can Target 'Undruggable' Proteins in Cancer and Alzheimer's

Hacker News - AIJul 22

AI-driven drug discovery is enabling the design of molecules that can target previously "undruggable" proteins involved in diseases like cancer and Alzheimer's. This breakthrough expands the range of treatable conditions and demonstrates AI's transformative potential in accelerating and broadening pharmaceutical innovation.